| DRH.F344-(D1Mgh8-D1Mgh12)/Shigm |
area of liver occupied by tumorous lesions as percentage of total liver area |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
12.6 |
% |
1.14 |
2.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per 40X field |
67415 |
750 |
| DRH/Seac |
area of liver occupied by fibrotic lesions to total liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
5.7 |
% |
0.33 |
0.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67434 |
750 |
| F344.GK-(D1Arb42a-D1Rat90)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.27 |
% |
0.13 |
0.23 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67180 |
333 |
| F344/Seac |
TUNEL-positive cell number to total cell number ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
hepatocyte apoptosis trait |
male |
84.0 days
| 6 |
|
1.3 |
% |
0.33 |
0.8 |
ex vivo light microscopy with digital image analysis |
liver |
0.0 |
|
56 |
days |
|
tunel hepatocytes to total hepatocytes ratio |
67545 |
750 |
| DRH/Seac |
TUNEL-positive cell number to total cell number ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
hepatocyte apoptosis trait |
male |
84.0 days
| 6 |
|
57.9 |
% |
2.98 |
7.3 |
ex vivo light microscopy with digital image analysis |
liver |
0.0 |
|
56 |
days |
|
tunel hepatocytes to total hepatocytes ratio |
67548 |
750 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
33.0 |
% |
|
8.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67442 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
16820.0 |
/cm3 |
|
5100.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
Add |
67445 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
19.0 |
% |
|
4.2 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67454 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
12820.0 |
/cm3 |
|
2800.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). |
67453 |
655 |
| F344.GK-(D1Got250-D1Rat90)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
59.7 |
% |
1.1 |
1.91 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67463 |
333 |
| MWF/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
27000.0 |
null |
3500.0 |
9260.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per kidney |
65397 |
117 |
| MWF/FubRkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 18 |
|
16.7 |
null |
1.1 |
4.67 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65458 |
117 |
| F344/DuCrlSwe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.28 |
% |
0.12 |
0.21 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67178 |
333 |
| F344/NRrrc |
intramuscular fat area |
control condition |
Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. |
intramuscular adipose amount |
male |
245.0 days
| 7 |
|
1.34 |
mm2 |
0.14 |
0.38 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67223 |
234 |
| F344/NRrrc |
intramuscular fat area to body weight ratio |
control condition |
Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. |
intramuscular adipose amount |
male |
245.0 days
| 7 |
|
3.62 |
(mm2/g)/1000 |
0.83 |
2.19 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67225 |
234 |
| F344/Seac |
area of liver occupied by fibrotic lesions to total liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
17.9 |
% |
1.35 |
3.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67432 |
750 |
| GK/Ox |
duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
0.87 |
mg |
0.2 |
0.49 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68758 |
1012 |
| BN/Crl |
splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
3.59 |
mg |
0.21 |
0.51 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68761 |
1012 |
| BN/Crl |
calculated total pancreatic islet beta cell weight |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
5.39 |
mg |
0.3 |
0.73 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68764 |
1012 |
| BN/SsNHsd |
artery lumen area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
CA = (IEL)2/4π |
0.45 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68087 |
329 |
| BN/SsNHsd |
artery tunica media thickness |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
MW=radius of entire vessel minus radius of circular area |
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68091 |
329 |
| SHR/NHsd |
artery tunica media area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
20 |
|
0.09 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
media area - error - % coefficient of variation |
68096 |
329 |
| BN/SsNHsd |
artery tunica media thickness |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
16 |
MW=radius of entire vessel minus radius of circular area |
0.03 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68097 |
329 |
| SHR/NHsd |
artery tunica media thickness |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
20 |
MW=radius of entire vessel minus radius of circular area |
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68098 |
329 |
| BN/SsNHsd |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
16 |
LS (lumen size) = CA - NIH area |
0.47 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68103 |
329 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
20 |
|
0.01 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
nih area - error - % coefficient of variation |
68100 |
329 |
| BN/Crl |
ratio of insulin-positive cell area to total area of splenic region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
0.8 |
% |
0.1 |
0.24 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68753 |
1012 |
| GK/Ox |
ratio of insulin-positive cell area to total area of splenic region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
0.34 |
% |
0.05 |
0.12 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68754 |
1012 |
| BN/Crl |
ratio of insulin-positive cell area to total area of duodenal region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
0.67 |
% |
0.07 |
0.17 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
ratio of duodenal IPCA |
68748 |
1012 |
| ACI/SegHsd |
area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.61 |
% |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67946 |
341 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.39 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69313 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
25 |
|
0.02 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69318 |
1136 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
15 |
|
14.96 |
% |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69335 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
17 |
|
23.76 |
% |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69341 |
1136 |
| SHR/NHsd |
artery tunica media thickness |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
15 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69353 |
1136 |
| COP |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy (for 202.5 days) |
De Miglio MR, et al., Int J Cancer 2004 Aug 10;111(1):9-16. |
liver integrity trait |
male |
days
| 10 |
|
83.0 |
% |
|
|
ex vivo light microscopy with digital image analysis |
liver |
0.0 |
|
224 |
days |
|
|
70203 |
1302 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled protein content diet (for 15 days) and 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy (for 202.5 days) |
De Miglio MR, et al., Int J Cancer 2004 Aug 10;111(1):9-16. |
liver integrity trait |
male |
days
| 10 |
|
19.0 |
% |
|
|
ex vivo light microscopy with digital image analysis |
liver |
0.0 |
|
224 |
days |
|
|
70204 |
1302 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
0.16 |
cm3 x 10000 |
|
0.09 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
|
67794 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
0.39 |
cm3 x 10000 |
|
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67795 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
0.18 |
cm3 x 10000 |
|
0.11 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67793 |
655 |
| ACI.FHH-(D1Mit18-D1Rat90)(D3Got102-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi |
ratio of the area occupied by protein casts to the total area of the kidney outer medulla outer stripe and cortex |
right nephrectomy (for 42 days) then controlled sodium content diet (0.4 %) (for 42 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
kidney integrity trait |
male |
84.0 days
| 4 |
|
3.29 |
% |
0.43 |
0.86 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
42 |
days |
|
area of cast to kidney area ratio |
84749 |
1600 |
| LEW/Mol |
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
kidney glomerulus integrity trait |
female |
77.0 days-105.0 days |
6 |
|
0.0 |
% |
0.0 |
0.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
7 |
days |
|
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
104044 |
809 |
| LEW/Mol |
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
kidney glomerulus integrity trait |
female |
77.0 days-105.0 days |
6 |
|
1.3 |
% |
0.78 |
1.9 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
3 |
days |
|
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
104042 |
809 |
| LEW/Maas |
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
kidney glomerulus integrity trait |
female |
77.0 days-105.0 days |
6 |
|
6.0 |
% |
2.04 |
5.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
7 |
days |
|
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
104043 |
809 |
| LEW/SsNHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.13 |
mm2 |
0.01 |
0.04 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110460 |
3107 |
| MNS/NMco |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.13 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110463 |
3107 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.14 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110464 |
3107 |
| DA/OlaHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.11 |
mm2 |
0.01 |
0.03 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110465 |
3107 |
| SR/Jr |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
8 |
|
0.04 |
mm2 |
0.01 |
0.03 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110468 |
3107 |
| LEW/SsNHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110471 |
3107 |
| SR/Jr |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
8 |
|
21.9 |
% |
4.98 |
14.09 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110479 |
3107 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
27.5 |
% |
3.5 |
10.5 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110481 |
3107 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
14 |
|
0.18 |
mm2 |
0.0 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110491 |
3107 |
| BN/SsNHsd |
circular vessel area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
0.47 |
mm2 |
0.03 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110510 |
3107 |
| Hsd:WI |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
-2.0 days
| 15 |
|
17.5 |
/mm3 |
1.1 |
4.26 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
110786 |
3187 |
| Hsd:WI |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
7.0 days
| 15 |
|
16.2 |
/mm3 |
2.9 |
11.23 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
110788 |
3187 |
| SHR/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney glomerulus quantity |
male |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
36979.0 |
null |
1352.0 |
3577.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
108973 |
3133 |
| ACI/SegHsd |
area of individual ventral prostate tumorous lesion with round, irregular size nuclei |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.73 |
mm2 |
0.36 |
1.24 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109961 |
341 |
| DRH.F344-(D1Mgh8-D1Mgh12)/Shigm |
liver tumorous lesion number to liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
5407.34 |
/cm2 |
359.37 |
880.26 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/40x field |
67407 |
750 |
| DRH/Seac |
area of individual liver tumorous lesion |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
0.01 |
mm2 |
0.0 |
0.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67431 |
750 |
| DRH.F344-(D1Mgh8-D1Mgh12)/Shigm |
area of individual liver tumorous lesion |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
0.02 |
mm2 |
0.0 |
0.01 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67430 |
750 |
| DRH.F344-(D1Mgh8-D1Mgh12)/Shigm |
area of liver occupied by fibrotic lesions to total liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
11.3 |
% |
1.18 |
2.9 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67433 |
750 |
| F344.GK-(D1Rat83-D1Rat376)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.23 |
% |
0.14 |
0.24 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67183 |
333 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
10.0 |
% |
|
4.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
|
67450 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
11630.0 |
/cm3 |
|
890.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). |
67449 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
7380.0 |
/cm3 |
|
920.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
Add |
67457 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
69.0 |
% |
|
9.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67458 |
655 |
| F344.GK-(D1Rat83-D1Rat376)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
60.2 |
% |
1.2 |
2.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67465 |
333 |
| MWF-Chr 6SHR/Rkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
34600.0 |
null |
5700.0 |
15080.78 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per kidney |
65398 |
117 |
| MWF/FubRkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 18 |
|
3.8 |
null |
0.8 |
3.39 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65461 |
117 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 9 |
|
13.8 |
% |
0.8 |
2.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
remodeling/total ratio |
69145 |
950 |
| SHR/Fub |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
kidney integrity trait |
male |
126.0 days
| 8 |
|
2.4 |
% |
0.11 |
0.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67838 |
325 |
| MWF/Fub |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, et al., J Am Soc Nephrol 2003 Dec;14(12):3081-9. |
kidney integrity trait |
male |
126.0 days
| 8 |
|
6.4 |
% |
0.28 |
0.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67837 |
325 |
| BN/Crl |
duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
1.38 |
mg |
0.1 |
0.24 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68757 |
1012 |
| BN/Crl |
calculated total pancreatic islet beta cell weight |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
4.9 |
mg |
0.19 |
0.47 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68765 |
1012 |
| F344/NHsd |
liver tumorous lesion number |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 12 |
|
126820.0 |
null |
9698.0 |
33594.86 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
CMO:0001068 |
68349 |
912 |
| SHR/NHsd |
artery tunica media thickness |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
18 |
MW=radius of entire vessel minus radius of circular area |
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68092 |
329 |
| BN/SsNHsd |
artery lumen area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
16 |
CA = (IEL)2/4π |
0.5 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68093 |
329 |
| F344/NHsd |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 12 |
|
84.18 |
% |
3.64 |
12.61 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
|
68353 |
912 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
15.33 |
% |
|
0.74 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
pcna index |
68110 |
655 |
| GK/Ox |
ratio of insulin-positive cell area to total area of duodenal region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
0.39 |
% |
0.06 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
ratio of duodenal IPCA |
68751 |
1012 |
| F344/Jcl |
area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.25 |
% |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67947 |
341 |
| F344/NRrrc |
area of individual liver tumorous lesion |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 8 |
|
0.13 |
mm2 |
0.01 |
0.04 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
|
68159 |
890 |
| DRH/Seac |
liver tumorous lesion number |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 140 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
175.0 days
| 5 |
|
0.0 |
null |
0.0 |
0.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
69938 |
890 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
20 |
|
9.63 |
% |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69305 |
1136 |
| SHR/NHsd |
artery tunica media thickness |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
20 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69309 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
13 |
|
0.35 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69316 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.45 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69319 |
1136 |
| SHR/NHsd |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.45 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69323 |
1136 |
| SHR/NHsd |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69325 |
1136 |
| SHR/NHsd |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
14 |
|
0.14 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69338 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
17 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69342 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.52 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69343 |
1136 |
| BN/Crli |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
13.69 |
% |
1.99 |
8.9 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
|
67758 |
789 |
| SHR/NHsd |
artery lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
15 |
|
0.44 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69351 |
1136 |
| F344/NRrrc |
liver tumorous lesion number |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
female |
days
| 3 |
|
1424.0 |
null |
242.0 |
419.16 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
68617 |
950 |
| SS.MNS-(D2Mit6-Adh1)/Ayd |
aorta smooth muscle cell count per unit vessel length |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
blood vessel smooth muscle cell quantity |
male |
98.0 days
| 5 |
|
58.0 |
/um |
9.0 |
20.12 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
69030 |
1096 |
| SS/Jr |
aorta smooth muscle cell count per unit vessel length |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
blood vessel smooth muscle cell quantity |
male |
98.0 days
| 10 |
|
90.0 |
/um |
4.0 |
12.65 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/um - calculated aortic smooth muscle cell count |
69034 |
1096 |
| FHH.PCK-(D9Rat35-D9Rat70)/Mcwi |
area of liver occupied by fibrotic lesions to total liver area ratio |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver integrity trait |
male |
120.0 days
| 8 |
|
21.3 |
% |
5.6 |
15.84 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
Masson¿s Trichrome staining |
|
96912 |
1738 |
| ACI.FHH-(D1Mit18-D1Rat90)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Eur |
ratio of the area occupied by protein casts to the total area of the kidney outer medulla outer stripe and cortex |
right nephrectomy (for 42 days) then controlled sodium content diet (0.4 %) (for 42 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
kidney integrity trait |
male |
84.0 days
| 4 |
|
0.78 |
% |
0.17 |
0.34 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
42 |
days |
|
area of cast to kidney area ratio |
84751 |
1600 |
| MWF |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 10 |
|
87.0 |
% |
2.21 |
7.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100255 |
2459 |
| WKY |
kidney glomerulus volume |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus morphology trait |
male |
280.0 days
| 9 |
|
0.7 |
x 10E6 um3 |
0.02 |
0.07 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100252 |
2459 |
| WKY |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 9 |
|
4.0 |
% |
1.33 |
4.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100256 |
2459 |
| LEW/Mol |
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
mesangial cell morphology trait |
female |
77.0 days-105.0 days |
6 |
|
9.4 |
% |
1.92 |
4.7 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
7 |
days |
|
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
104048 |
809 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.16 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110455 |
3107 |
| SR/Jr |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
8 |
|
0.16 |
mm2 |
0.01 |
0.03 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110457 |
3107 |
| F344/Jcl |
area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.07 |
% |
0.05 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109892 |
341 |
| F344/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.05 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110473 |
3107 |
| SS/Jr |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.06 |
mm2 |
0.02 |
0.05 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110472 |
3107 |
| DA/OlaHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.04 |
mm2 |
0.01 |
0.01 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110476 |
3107 |
| AS |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
24.5 |
% |
5.01 |
13.26 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110480 |
3107 |
| SS/Jr |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
28.3 |
% |
6.87 |
21.72 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110483 |
3107 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110489 |
3107 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.2 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110488 |
3107 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
46.3 |
% |
1.71 |
5.41 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110493 |
3107 |
| BN/SsNHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
11 |
|
0.35 |
mm2 |
389.0 |
1290.17 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110494 |
3107 |
| BN/SsNHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
0.48 |
mm2 |
0.02 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110503 |
3107 |
| SHR/NHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
19 |
|
0.59 |
mm2 |
0.08 |
0.36 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110506 |
3107 |
| BN/SsNHsd |
artery lumen area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
0.41 |
mm2 |
0.03 |
0.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110505 |
3107 |
| SHR/NHsd |
circular vessel area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
19 |
|
0.46 |
mm2 |
0.05 |
0.22 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110507 |
3107 |
| MWF/FubRkb |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
-2.0 days
| 15 |
|
11.9 |
/mm3 |
1.8 |
6.97 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
110785 |
3187 |
| MWF/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney glomerulus quantity |
male |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
27028.0 |
null |
1322.0 |
3497.68 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
108972 |
3133 |
| MWF-Chr 8SHR/Rkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
male |
168.0 days
| 10 |
|
7.5 |
% |
0.3 |
0.95 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108982 |
3133 |
| F344/Jcl |
area of individual ventral prostate tumorous lesion with round, irregular size nuclei |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.22 |
mm2 |
0.11 |
0.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109962 |
341 |
| F344/Jcl |
area of individual prostate tumorous lesion |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.22 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0 |
|
|
|
|
|
65839 |
341 |
| ACI/SegHsd |
area of individual prostate tumorous lesion |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.78 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0 |
|
|
|
|
|
65838 |
341 |
| F344/Seac |
area of liver occupied by tumorous lesions as percentage of total liver area |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
44.2 |
% |
2.12 |
5.2 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per 40X field |
67414 |
750 |
| F344/Seac |
area of individual liver tumorous lesion |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
0.08 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67429 |
750 |
| F344.GK-(D1Mgh14-D1Rat90)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.07 |
% |
0.12 |
0.21 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67182 |
333 |
| F344/DuCrlSwe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
61.1 |
% |
1.1 |
1.91 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67185 |
333 |
| DRH.F344-(D1Mgh8-D1Mgh12)/Shigm |
TUNEL-positive cell number to total cell number ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
hepatocyte apoptosis trait |
male |
84.0 days
| 6 |
|
2.9 |
% |
0.61 |
1.5 |
ex vivo light microscopy with digital image analysis |
liver |
0.0 |
|
56 |
days |
|
tunel hepatocytes to total hepatocytes ratio |
67547 |
750 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
19.0 |
% |
|
5.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67446 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion diameter measurement |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
4.19 |
mm |
|
1.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
224 |
days |
intraperitoneal |
|
67460 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
38.6 |
null |
|
12.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
224 |
days |
intraperitoneal |
per liver |
67459 |
655 |
| F344.GK-(D1Arb42a-D1Rat90)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
61.8 |
% |
1.2 |
2.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67461 |
333 |
| F344.GK-(D1Mgh14-D1Rat90)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
57.4 |
% |
1.2 |
2.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67464 |
333 |
| BN |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy then 5-bromo-2'-deoxyuridine (50 mg/kg) (for 2 hours) |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 5 |
|
180.0 |
% |
4.0 |
8.94 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
69144 |
950 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 3 |
|
19.2 |
% |
2.8 |
4.85 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
69148 |
950 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 5 |
|
15.1 |
% |
1.1 |
2.46 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
224 |
days |
|
remodeling/total ratio |
69147 |
950 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 3 |
|
40.6 |
% |
5.4 |
9.35 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
224 |
days |
|
remodeling/total ratio |
69149 |
950 |
| F344/NRrrc |
benign liver tumor number |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 16 |
|
22.3 |
null |
2.0 |
8.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
490 |
days |
|
|
69151 |
950 |
| BN/Crl |
duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
1.7 |
mg |
0.12 |
0.29 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68756 |
1012 |
| GK/Ox |
duodenal region pancreatic beta cell weight calculated as the product of pancreas duodenal region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
0.95 |
mg |
0.08 |
0.2 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68759 |
1012 |
| GK/Ox |
splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
1.08 |
mg |
0.17 |
0.42 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68762 |
1012 |
| GK/Ox |
calculated total pancreatic islet beta cell weight |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
2.18 |
mg |
0.33 |
0.81 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68767 |
1012 |
| SHR/NHsd |
artery lumen area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
20 |
CA = (IEL)2/4π |
0.35 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68094 |
329 |
| BN/SsNHsd |
artery tunica media area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
16 |
|
0.07 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
media area - error - % coefficient of variation |
68095 |
329 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
16 |
|
0.03 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
nih area - error - % coefficient of variation |
68099 |
329 |
| SHR/NHsd |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
20 |
LS (lumen size) = CA - NIH area |
0.34 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68104 |
329 |
| BN/SsNHsd |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 7 |
|
19.83 |
% |
2.09 |
5.53 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
|
68354 |
912 |
| BN/Crl |
ratio of insulin-positive cell area to total area of splenic region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
0.75 |
% |
0.13 |
0.32 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68752 |
1012 |
| SHR/FubRkb |
kidney glomerulus count |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
37000.0 |
null |
5900.0 |
15609.93 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per kidney |
65396 |
117 |
| MWF-Chr 6SHR/Rkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 19 |
|
15.2 |
null |
1.1 |
4.79 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65457 |
117 |
| DRH/Seac |
area of liver occupied by tumorous lesions as percentage of total liver area |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 10 |
|
0.15 |
% |
0.02 |
0.07 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
% tumorous foci area in liver |
68163 |
890 |
| F344/NHsd |
hepatocellular carcinoma tumor number |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 mg/kg) (for 490 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 9 |
|
3.5 |
null |
0.23 |
0.69 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
490 |
days |
|
|
68391 |
912 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery tunica media area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.08 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69314 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery tunica media thickness |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69321 |
1136 |
| SHR/NHsd |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.12 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69324 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.14 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69330 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.5 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69329 |
1136 |
| SHR/NHsd |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
14 |
|
0.54 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69337 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.12 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69348 |
1136 |
| F344/Crli |
volume of individual liver tumorous lesion |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
3.26 |
cm3 x 10000 |
0.33 |
1.48 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
|
67731 |
789 |
| F344/NRrrc |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
female |
days
| 3 |
|
8.92 |
% |
2.85 |
4.94 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
68619 |
950 |
| SS.MNS-(D2Mit6-D2Rat166)/Ayd |
aorta smooth muscle cell count per unit vessel length |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
blood vessel smooth muscle cell quantity |
male |
98.0 days
| 8 |
|
170.0 |
/um |
11.0 |
31.11 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/um - calculated aortic smooth muscle cell count |
69031 |
1096 |
| ACI.FHH-(D1Mit18-D1Rat90)(D3Rat6-D3Got149)(D14Mit11-D14Rat33)(D14Rat65-D14Rat90)/Mcwi |
ratio of the area occupied by protein casts to the total area of the kidney outer medulla outer stripe and cortex |
right nephrectomy (for 42 days) then controlled sodium content diet (0.4 %) (for 42 days) |
O'Meara CC, et al., J Am Soc Nephrol. 2011 Mar;22(3):518-25. Epub 2010 Dec 2. |
kidney integrity trait |
male |
84.0 days
| 3 |
|
1.18 |
% |
0.26 |
0.45 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
42 |
days |
|
area of cast to kidney area ratio |
84750 |
1600 |
| MWF |
kidney glomerulus volume |
control condition (for 420 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus morphology trait |
male |
420.0 days
| 10 |
|
1.85 |
x 10E6 um3 |
0.08 |
0.25 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100253 |
2459 |
| MWF |
kidney sclerotic glomerular volume to total kidney glomerular volume ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 10 |
|
35.8 |
% |
3.16 |
10.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100259 |
2459 |
| AS |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.2 |
mm2 |
0.04 |
0.12 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110458 |
3107 |
| Hsd:SD |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
15 |
|
0.14 |
mm2 |
0.02 |
0.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110456 |
3107 |
| SS/Jr |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.21 |
mm2 |
0.02 |
0.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110461 |
3107 |
| F344/NHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.17 |
mm2 |
0.03 |
0.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110462 |
3107 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.03 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110466 |
3107 |
| F344/Jcl |
area of individual ventral prostate tumorous lesion with a solid structure |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.06 |
mm2 |
0.05 |
0.14 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109890 |
341 |
| ACI/SegHsd |
area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.09 |
% |
0.38 |
1.31 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109891 |
341 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.05 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110475 |
3107 |
| MNS/NMco |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110474 |
3107 |
| MNS/NMco |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
32.0 |
% |
5.97 |
15.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110485 |
3107 |
| DA/OlaHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
38.3 |
% |
5.32 |
14.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110487 |
3107 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
35.2 |
% |
2.34 |
7.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110486 |
3107 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
19.9 |
% |
3.49 |
11.04 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110490 |
3107 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
0.08 |
mm2 |
0.0 |
0.01 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110492 |
3107 |
| BN/SsNHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
11 |
|
0.35 |
mm2 |
0.04 |
0.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110496 |
3107 |
| BN/SsNHsd |
circular vessel area |
sham surgical control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
11 |
|
0.28 |
mm2 |
0.03 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110495 |
3107 |
| BN/SsNHsd |
circular vessel area |
sham surgical control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
11 |
|
0.28 |
mm2 |
0.03 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110497 |
3107 |
| SHR/NHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
0.4 |
mm2 |
0.06 |
0.22 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110499 |
3107 |
| SHR/NHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
0.4 |
mm2 |
0.06 |
0.22 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110501 |
3107 |
| SHR/NHsd |
artery lumen area |
sham surgical control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
0.34 |
mm2 |
0.23 |
0.78 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110500 |
3107 |
| BN/SsNHsd |
circular vessel area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
0.47 |
mm2 |
0.03 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110504 |
3107 |
| SHR/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
male |
168.0 days
| 10 |
|
3.1 |
% |
0.2 |
0.63 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108980 |
3133 |
| MWF/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
male |
168.0 days
| 10 |
|
7.5 |
% |
0.5 |
1.58 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108984 |
3133 |
| MWF/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
female |
168.0 days
| 10 |
|
4.9 |
% |
0.3 |
0.95 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108985 |
3133 |
| DRH/Seac |
liver tumorous lesion number to liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
1571.9 |
/cm2 |
205.35 |
503.01 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/40x field |
67408 |
750 |
| DRH/Seac |
area of liver occupied by tumorous lesions as percentage of total liver area |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
3.0 |
% |
0.65 |
1.6 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per 40X field |
67416 |
750 |
| F344.GK-(D1Rat175-D1Rat90)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.45 |
% |
0.13 |
0.23 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67193 |
333 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
3840.0 |
/cm3 |
|
1450.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). |
67437 |
655 |
| F344.GK-(D1Rat175-D1Rat90)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
58.7 |
% |
1.1 |
1.91 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67462 |
333 |
| F344.GK-(D1Swe4-D1Rat85)/Swe |
beta cell area to total pancreatic islet area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 3 |
|
60.4 |
% |
1.1 |
1.91 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67466 |
333 |
| MWF-Chr 6SHR/Rkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 19 |
|
1.6 |
null |
0.4 |
1.74 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65460 |
117 |
| OLETF |
intramuscular fat area |
control condition |
Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. |
intramuscular adipose amount |
male |
245.0 days
| 7 |
|
3.26 |
mm2 |
0.2 |
0.52 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67222 |
234 |
| OLETF |
intramuscular fat area to body weight ratio |
control condition |
Tanomura H, et al., J Vet Med Sci 2002 Jan;64(1):45-50. |
intramuscular adipose amount |
male |
245.0 days
| 7 |
|
5.01 |
(mm2/g)/1000 |
0.87 |
2.29 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
67224 |
234 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy then 5-bromo-2'-deoxyuridine (50 mg/kg) (for 2 hours) |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 5 |
|
1070.0 |
% |
143.0 |
319.76 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
69143 |
950 |
| F344/NRrrc |
liver remodeling tumorous lesion number to liver total tumorous lesion number ratio |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 5 |
|
30.4 |
% |
2.7 |
6.04 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
105 |
days |
|
remodeling/total ratio |
69146 |
950 |
| F344/NRrrc |
percentage of study population developing benign liver tumors during a period of time |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 16 |
|
100.0 |
% |
5.4 |
21.6 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
490 |
days |
|
benign liver tumor incidence |
69150 |
950 |
| BN/Crl |
splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
3.75 |
mg |
0.28 |
0.69 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68760 |
1012 |
| GK/Ox |
splenic region pancreatic beta cell weight calculated as the product of pancreas splenic region weight and corresponding beta cell fractional area |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
1.22 |
mg |
0.26 |
0.64 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68763 |
1012 |
| GK/Ox |
calculated total pancreatic islet beta cell weight |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
2.0 |
mg |
0.4 |
0.98 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68766 |
1012 |
| BN/SsNHsd |
volume of individual liver tumorous lesion |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 7 |
|
0.12 |
cm3 x 10000 |
0.03 |
0.07 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
|
68352 |
912 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
12.14 |
% |
|
1.45 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
pcna index |
68105 |
655 |
| BN/Crl |
ratio of insulin-positive cell area to total area of duodenal region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
0.56 |
% |
0.12 |
0.29 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
ratio of duodenal IPCA |
68749 |
1012 |
| F344/NRrrc |
area of liver occupied by tumorous lesions as percentage of total liver area |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 8 |
|
15.2 |
% |
1.59 |
4.5 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
% tumorous foci area in liver |
68162 |
890 |
| DRH/Seac |
area of individual liver tumorous lesion |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 10 |
|
0.01 |
mm2 |
0.0 |
0.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
|
68160 |
890 |
| BN/SsNHsd |
hepatocellular carcinoma tumor number |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 mg/kg) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 10 |
|
1.3 |
null |
0.13 |
0.41 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
490 |
days |
|
|
68389 |
912 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
13 |
|
28.31 |
% |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69311 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
25 |
|
12.6 |
% |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69317 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery lumen area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.39 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69326 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69328 |
1136 |
| SHR/NHsd |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
14 |
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69339 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.48 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69347 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
17 |
|
0.45 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69350 |
1136 |
| F344/Crli |
liver tumorous lesion number to liver volume ratio |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
7875.0 |
/cm3 |
624.0 |
2790.61 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
need to update double congenicstrain |
67713 |
789 |
| BN/Crli |
volume of individual liver tumorous lesion |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
0.09 |
cm3 x 10000 |
0.02 |
0.09 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
|
67736 |
789 |
| F344/Crli |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
80.11 |
% |
6.33 |
28.32 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
|
67755 |
789 |
| SHR/NHsd |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
15 |
|
0.42 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69354 |
1136 |
| BN |
liver tumorous lesion number |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
female |
days
| 3 |
|
1717.0 |
null |
227.0 |
393.18 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
68618 |
950 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
ovariectomy then testosterone (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then testosterone (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
3.9 |
cm3 x 10000 |
|
0.74 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67796 |
655 |
| SS.MNS-(D2Mit6-D2Rat303)/Ayd |
aorta smooth muscle cell count per unit vessel length |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
blood vessel smooth muscle cell quantity |
male |
98.0 days
| 8 |
|
134.0 |
/um |
21.0 |
59.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/um - calculated aortic smooth muscle cell count |
69032 |
1096 |
| MWF |
kidney sclerotic glomeruli count to total glomeruli count ratio |
controlled lisinopril content drinking water (80-100 mg/l) (for 140 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
420.0 days
| 10 |
|
85.0 |
% |
2.53 |
8.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100258 |
2459 |
| WKY |
kidney sclerotic glomerular volume to total kidney glomerular volume ratio |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
280.0 days
| 9 |
|
0.3 |
% |
0.13 |
0.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100260 |
2459 |
| MWF |
kidney sclerotic glomerular volume to total kidney glomerular volume ratio |
controlled lisinopril content drinking water (80-100 mg/l) (for 140 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
420.0 days
| 10 |
|
24.8 |
% |
1.49 |
4.7 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100262 |
2459 |
| ACI/SegHsd |
area of individual ventral prostate tumorous lesion with a solid structure |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.17 |
mm2 |
0.36 |
1.25 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109889 |
341 |
| Hsd:SD |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
15 |
|
20.7 |
% |
3.71 |
14.37 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110478 |
3107 |
| LEW/SsNHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
10 |
|
28.0 |
% |
4.17 |
13.19 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110482 |
3107 |
| SHR/NHsd |
circular vessel area |
sham surgical control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
12 |
|
0.34 |
mm2 |
0.02 |
0.08 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110498 |
3107 |
| MWF/FubRkb |
kidney glomerular density |
control condition |
Freese A, etal., J Perinat Med. 2013 May;41(3):295-9. doi: 10.1515/jpm-2012-0178. |
kidney glomerulus quantity |
not specified |
7.0 days
| 15 |
|
11.3 |
/mm3 |
2.6 |
10.07 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
number of glomeruli per volume of kidney (CMO:0003799) |
110787 |
3187 |
| MWF-Chr 8SHR/Rkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
female |
168.0 days
| 10 |
|
3.3 |
% |
0.1 |
0.32 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108983 |
3133 |
| F344/Jcl |
area of ventral prostate occupied by tumorous lesions with round, irregular size nuclei to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 8 |
|
0.24 |
% |
0.12 |
0.33 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109964 |
341 |
| ACI/SegHsd |
area of ventral prostate occupied by tumorous lesions with round, irregular size nuclei to total ventral prostate area ratio |
control condition |
Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6. |
prostate integrity trait |
male |
900.0 days
| 12 |
|
1.57 |
% |
0.38 |
1.31 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
109963 |
341 |
| F344/Seac |
liver tumorous lesion number to liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 56 days) |
Liu H, et al., Cancer Sci 2005 Mar;96(3):164-9. |
liver integrity trait |
male |
84.0 days
| 6 |
|
6036.1 |
/cm2 |
693.06 |
1697.65 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/40x field |
67402 |
750 |
| F344.GK-(D1Got250-D1Rat90)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.08 |
% |
0.08 |
0.14 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67181 |
333 |
| F344.GK-(D1Swe4-D1Rat85)/Swe |
pancreatic islet area to total pancreatic area ratio |
control condition |
Granhall C, et al., Diabetes. 2006 Dec;55(12):3494-500. |
islet of Langerhans morphology trait |
male |
60.0 days
| 3 |
|
1.26 |
% |
0.11 |
0.19 |
ex vivo light microscopy with digital image analysis |
pancreas |
0.0 |
|
|
|
|
|
67184 |
333 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
59.0 |
% |
|
9.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
|
67438 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
liver tumorous lesion number to liver volume ratio |
orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
9420.0 |
/cm3 |
|
990.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
Add "liver tumorous lesion number to liver volume ratio" (new term) as child of "calculated liver tumorous lesion number" (new term). |
67441 |
655 |
| F344/NRrrc |
malignant liver tumor number |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 16 |
|
2.2 |
null |
0.2 |
0.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
490 |
days |
|
check malignant |
69153 |
950 |
| F344/NRrrc |
percentage of study population developing malignant liver tumors during a period of time |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
male |
days
| 16 |
|
100.0 |
% |
5.4 |
21.6 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
490 |
days |
|
check malignant |
69152 |
950 |
| BN/SsNHsd |
liver tumorous lesion number |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 7 |
|
155800.0 |
null |
19408.0 |
51348.74 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
CMO:0001068 |
68350 |
912 |
| SHR/NHsd |
artery tunica media area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
18 |
|
0.09 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68090 |
329 |
| BN/SsNHsd |
artery tunica media area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
12 |
|
0.09 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68089 |
329 |
| SHR/NHsd |
artery lumen area |
control condition |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery morphology trait |
male |
133.0 days-140.0 days |
18 |
CA = (IEL)2/4π |
0.34 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
error - % coefficient of variation |
68088 |
329 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
20 |
|
11.6 |
% |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
% nih area - error - % coefficient of variation |
68102 |
329 |
| BN/SsNHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Nestor AL, et al., Physiol Genomics. 2006 Apr 13;25(2):286-93. Epub 2006 Jan 24. |
iliac artery integrity trait |
male |
133.0 days-140.0 days |
16 |
|
27.1 |
% |
|
|
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
% nih area - error - % coefficient of variation |
68101 |
329 |
| F344/NHsd |
volume of individual liver tumorous lesion |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 210 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 1999 Sep 15;59(18):4651-7. |
liver integrity trait |
not specified |
days
| 12 |
|
2.95 |
cm3 x 10000 |
0.35 |
312.98 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine |
224 |
days |
|
|
68351 |
912 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
2.76 |
% |
|
1.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
pcna index |
68108 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
6.42 |
% |
|
0.99 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
pcna index |
68106 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
orchiectomy then 17 beta-estradiol (3.3 mg/kg) (for 21 days) then N-nitrosodiethylamine (200 mg/kg) (for 56 days) then 17 beta-estradiol (10 mg/kg) (for 35 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
3.55 |
% |
|
0.98 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
pcna index |
68107 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
ratio of proliferating cell nuclear antigen-positive cells to total liver tumorous lesion cells |
ovariectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
female |
days
| |
|
10.67 |
% |
|
1.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
pcna index |
68109 |
655 |
| GK/Ox |
ratio of insulin-positive cell area to total area of duodenal region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
male |
60.0 days
| 6 |
|
0.34 |
% |
0.06 |
0.15 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
ratio of duodenal IPCA |
68750 |
1012 |
| GK/Ox |
ratio of insulin-positive cell area to total area of splenic region of pancreas |
fasting (between 16 and 18 hours) |
Finlay C, et al., Mamm Genome. 2010 Oct;21(9-10):499-508. Epub 2010 Sep 29. |
pancreatic beta cell morphology trait |
female |
60.0 days
| 6 |
|
0.34 |
% |
0.04 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68755 |
1012 |
| DRH/Seac |
liver tumorous lesion number to liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 10 |
|
23.8 |
/cm2 |
2.75 |
8.7 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
|
68158 |
890 |
| F344/NRrrc |
liver tumorous lesion number to liver area ratio |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 49 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
84.0 days
| 8 |
|
120.0 |
/cm2 |
4.95 |
14.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
8 wks in text, inconsistent |
|
68157 |
890 |
| F344/NRrrc |
liver tumorous lesion number |
controlled 3-methyl-4'-dimethylaminoazobenzene content diet (0.06 %) (for 140 days) |
Yan Y, et al., Carcinogenesis 2002 Jan;23(1):189-96. |
liver integrity trait |
not specified |
175.0 days
| 11 |
|
6.5 |
null |
0.27 |
0.9 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
68166 |
890 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
20 |
|
0.01 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69306 |
1136 |
| SHR/NHsd |
artery lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
20 |
|
0.38 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69307 |
1136 |
| SHR/NHsd |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
20 |
|
0.37 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69310 |
1136 |
| SHR/NHsd |
artery tunica media area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
20 |
|
0.1 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69308 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
13 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69312 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery tunica media thickness |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69315 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery tunica media area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.11 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69320 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
lesioned artery residual lumen area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
25 |
|
0.04 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69322 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)/Mco |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
13 |
|
0.1 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69327 |
1136 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery integrity trait |
male |
126.0 days-140.0 days |
15 |
|
0.02 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69336 |
1136 |
| SHR.BN-(D6Rat40-D6Rat170)/Mco |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
25 |
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69331 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media thickness |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69349 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media thickness |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.05 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69345 |
1136 |
| SHR.BN-(D3Rat159-D3Rat1)(D6Rat40-D6Rat170)/Mco |
artery tunica media area |
control condition |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
17 |
|
0.14 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
|
|
|
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69344 |
1136 |
| BN/Crli |
liver tumorous lesion number to liver volume ratio |
N-nitrosodiethylamine (150 mg/kg) then 2-acetamidofluorene (0.02 %) (for 15 days) then partial hepatectomy |
De Miglio MR, et al., Cancer Res 2002 Aug 1;62(15):4459-63. |
liver integrity trait |
not specified |
days
| 20 |
|
11142.0 |
/cm3 |
930.0 |
4159.09 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection |
224 |
days |
150mg/Kg body weight |
update term and unit |
67721 |
789 |
| SHR/NHsd |
artery tunica media area |
balloon angioplasty |
Nestor Kalinoski AL, et al., Hypertension. 2010 Feb;55(2):555-61. Epub 2009 Dec 21. |
iliac artery morphology trait |
male |
126.0 days-140.0 days |
15 |
|
0.1 |
mm2 |
|
|
ex vivo light microscopy with digital image analysis |
iliac artery |
0.0 |
balloon vascular injury |
56 |
days |
|
the error is reported as +/- %CV = (standard deviation/mean) � 100 |
69352 |
1136 |
| BN |
volume of liver occupied by tumorous lesions as percentage of total liver volume |
N-nitrosodiethylamine (150 mg/kg) then controlled 2-acetamidofluorene content diet (0.02 %) (for 14 days) then partial hepatectomy |
Pascale RM, et al., Carcinogenesis. 1996 Aug;17(8):1765-8. |
liver integrity trait |
female |
days
| 3 |
|
1.61 |
% |
0.46 |
0.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethtlamine injection |
56 |
days |
|
|
68620 |
950 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
4.76 |
cm3 x 10000 |
|
0.4 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
|
|
67791 |
655 |
| F344.BN-(D16Mit5-D16Rat75) |
volume of liver occupied by tumorous lesions |
orchiectomy then N-nitrosodiethylamine (200 mg/kg) (for 56 days) |
De Miglio MR, et al., Cancer Res. 2006 Nov 1;66(21):10384-90. |
liver integrity trait |
male |
days
| |
|
0.47 |
cm3 x 10000 |
|
0.13 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
N-nitrosodiethylamine injection at 200mg/kg |
56 |
days |
intraperitoneal |
|
67792 |
655 |
| SS.MNS-(Mme-D2Rat131)/Ayd |
aorta smooth muscle cell count per unit vessel length |
controlled sodium content diet (0.2 %) (for 14 days) then controlled sodium content diet (2 %) (for 63 days) |
Dutil J, et al., Physiol Genomics 2005 Mar 1;. |
blood vessel smooth muscle cell quantity |
male |
98.0 days
| 4 |
|
71.0 |
/um |
4.0 |
8.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
/um - calculated aortic smooth muscle cell count |
69033 |
1096 |
| PCK-Pkhd1pck/CrljCrl |
area of liver occupied by fibrotic lesions to total liver area ratio |
control condition |
O'Meara CC, et al., Physiol Genomics. 2012 Aug 1;44(15):741-53. doi: 10.1152/physiolgenomics.00187.2011. Epub 2012 Jun 5. |
liver integrity trait |
male |
120.0 days
| 8 |
|
23.5 |
% |
4.8 |
13.58 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
Masson¿s Trichrome staining |
|
96913 |
1738 |
| SHR/FubRkb |
count of superficial glomeruli not directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 10 |
|
0.3 |
null |
0.1 |
0.32 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65456 |
117 |
| SHR/FubRkb |
count of superficial glomeruli directly contacting the kidney surface |
control condition |
Schulz A, et al., J Am Soc Nephrol. 2007 Jan;18(1):113-21 |
kidney glomerulus quantity |
not specified |
168.0 days
| 10 |
|
0.0 |
null |
0.0 |
0.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
per section |
65459 |
117 |
| MWF |
kidney glomerulus volume |
control condition (for 280 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus morphology trait |
male |
280.0 days
| 10 |
|
1.75 |
x 10E6 um3 |
0.06 |
0.2 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100251 |
2459 |
| MWF |
kidney glomerulus volume |
controlled lisinopril content drinking water (80-100 mg/l) (for 140 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus morphology trait |
male |
420.0 days
| 10 |
|
1.4 |
x 10E6 um3 |
0.08 |
0.25 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100254 |
2459 |
| MWF |
kidney sclerotic glomeruli count to total glomeruli count ratio |
control condition (for 420 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
420.0 days
| 10 |
|
99.0 |
% |
0.63 |
2.0 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100257 |
2459 |
| MWF |
kidney sclerotic glomerular volume to total kidney glomerular volume ratio |
control condition (for 420 days) |
Macconi D, et al., Am J Pathol. 2009 Mar;174(3):797-807. Epub 2009 Jan 22. |
kidney glomerulus integrity trait |
male |
420.0 days
| 10 |
|
62.0 |
% |
3.1 |
9.8 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
100261 |
2459 |
| LEW/Maas |
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
kidney glomerulus integrity trait |
female |
77.0 days-105.0 days |
6 |
|
22.1 |
% |
3.8 |
9.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
3 |
days |
|
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
104041 |
809 |
| LEW/Maas |
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
mesangial cell morphology trait |
female |
77.0 days-105.0 days |
6 |
|
1.0 |
% |
0.69 |
1.7 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
3 |
days |
|
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
104045 |
809 |
| LEW/Mol |
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
mesangial cell morphology trait |
female |
77.0 days-105.0 days |
6 |
|
1.0 |
% |
0.37 |
0.9 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
3 |
days |
|
ratio of number of glomeruli with microaneurysms to number of total glomeruli |
104046 |
809 |
| LEW/Maas |
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
anti-Thy1 antibody (2 mg/kg) (between 3 and 21 days) |
Ijpelaar DH, et al., Physiol Genomics. 2008 Oct 8;35(2):173-81. Epub 2008 Aug 5. |
mesangial cell morphology trait |
female |
77.0 days-105.0 days |
6 |
|
26.1 |
% |
5.84 |
14.3 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
7 |
days |
|
ratio of glomerular area occupied by activated mesangial cells to total glomerular area |
104047 |
809 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area including tunica media |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.13 |
mm2 |
0.01 |
0.04 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110459 |
3107 |
| Hsd:SD |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
15 |
|
0.03 |
mm2 |
0.0 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110467 |
3107 |
| WKY/NHsd |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110470 |
3107 |
| AS |
artery neointimal hyperplastic lesion area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
7 |
|
0.04 |
mm2 |
0.01 |
0.02 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110469 |
3107 |
| SHR/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
15.1 |
% |
2.98 |
8.94 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110477 |
3107 |
| F344/NHsd |
artery neointimal hyperplastic lesion area to total wall area ratio |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery integrity trait |
male |
119.0 days-133.0 days |
9 |
|
30.9 |
% |
2.86 |
8.58 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110484 |
3107 |
| BN/SsNHsd |
circular vessel area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
23 |
|
0.48 |
mm2 |
0.02 |
0.1 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110502 |
3107 |
| SHR/NHsd |
artery lumen area |
control condition |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
19 |
|
0.59 |
mm2 |
0.08 |
0.36 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110508 |
3107 |
| SHR/NHsd |
artery lumen area |
balloon angioplasty |
Assadnia S, etal., Circ Res. 1999 Jun 11;84(11):1252-7. doi: 10.1161/01.res.84.11.1252. |
iliac artery morphology trait |
male |
119.0 days-133.0 days |
19 |
|
0.43 |
mm2 |
0.04 |
0.19 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
110509 |
3107 |
| MWF-Chr 8SHR/Rkb |
kidney glomerulus count |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney glomerulus quantity |
male |
28.0 days
| 7 |
N(glom)=1/SSF x 1/ASF x Ps/Pf x ΣQ-/2 |
23771.0 |
null |
1352.0 |
3577.06 |
ex vivo light microscopy with digital image analysis |
|
0.0 |
|
|
|
|
|
108971 |
3133 |
| SHR/FubRkb |
kidney fibrotic lesion area to total kidney area ratio |
control condition |
Schulz A, etal., Physiol Genomics. 2008 Sep 17;35(1):30-5. Epub 2008 Jul 22. |
kidney integrity trait |
female |
168.0 days
| 10 |
|
4.0 |
% |
0.2 |
0.63 |
ex vivo light microscopy with digital image analysis |
kidney |
0.0 |
|
|
|
|
|
108981 |
3133 |